| Author | Message | ||
     Gudivada04 Bewarse Legend Username: Gudivada04 Post Number: 45216 Registered: 09-2004 Rating: N/A |
After the market closed yesterday, Sarepta Therapeutics announced that its gene therapy failed to be effective in trials. Because of this announcement, Sarepta Therapeutics’ stock is being quoted down over 50%. So, I recommend selling this stock today, as the market's reaction to this news indicates that Sarepta Therapeutics’ stock is unlikely to make new highs any time soon. I understand that this sell might be disappointing, since at one point we had significant gains in our position. However, this can happen with any of our stocks from time to time when an unexpected announcement occurs. But I believe it's better to take our gains now, rather than take a loss later. Also, in my view, we will have many more extraordinary opportunities in our portfolio in 2021 and beyond! So, I recommend you follow our buy and sell recommendations in our model portfolio, and here’s your action to take: Action to take: Sell Sarepta Therapeutics Inc. (Nasdaq: SRPT) at the market. |